Syneos Health Delays Fourth Quarter and Year End 2018 Earnings Release Date and Conference Call
The Company has determined that additional time is needed for management to conduct a review of the Company’s internal control over financial reporting in conjunction with the finalization of the Company’s Form 10-K. On
As an additional measure prior to the Company filing the Form 10-K, the Audit Committee of the Company’s Board of Directors, with the assistance of outside counsel and accounting advisors, is conducting an independent review of the Company’s revenue accounting policies, internal controls and related matters.
Prior to receiving notice of the
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, the Company’s expectations that it will file the Form 10-K within the time period prescribed by Rule 12b-25. These forward-looking statements are based on management’s current expectations.
These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the following: that the Company is not able to complete its Form 10-K in the time period that it currently expects, the risk that the Company determines that there are deficiencies in its internal control over financial reporting that could materially affect our financial statements, and the risk that the nature and scope of the
Senior Vice President, Investor Relations
+1 919 745 2745
+1 202 210 5992
Source: Syneos Health